Correction to: Cancer Commun (2019) 39:40 https://doi.org/10.1186/s40880-019-0380-x
In the original publication of this article [1], the first affiliation name in the Author details section should be updated to ‘Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China’ because the affiliation has been renamed from Jun. 15th, 2019.
Reference
Liao J-F, Zhang Q, Du X-J, Lan M, Liu S, **a Y-F, Cai X-Y, Luo W. Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis. Cancer Commun. 2019;39:40. https://doi.org/10.1186/s40880-019-0380-x.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Liao, JF., Zhang, Q., Du, XJ. et al. Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis. Cancer Commun 39, 50 (2019). https://doi.org/10.1186/s40880-019-0396-2
Published:
DOI: https://doi.org/10.1186/s40880-019-0396-2